Publications by authors named "Matteo Serino"

47Publications

Evolution of Gut Microbiome and Metabolome in Suspected Necrotizing Enterocolitis: A Case-Control Study.

J Clin Med 2020 Jul 17;9(7). Epub 2020 Jul 17.

IRSD, Université de Toulouse, INSERM, INRAE, ENVT, UPS, 31024 Toulouse, France.

View Article and Find Full Text PDF
July 2020

The Genotoxin Colibactin Shapes Gut Microbiota in Mice.

mSphere 2020 07 1;5(4). Epub 2020 Jul 1.

IRSD, Université de Toulouse, INSERM, INRAE, ENVT, UPS, Toulouse, France

View Article and Find Full Text PDF
July 2020

Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases.

Rev Endocr Metab Disord 2019 12;20(4):449-459

INSERM U1048, F-31432 Toulouse, France, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), F-31432, Toulouse, France.

View Article and Find Full Text PDF
December 2019

A Two-Week Treatment with Plant Extracts Changes Gut Microbiota, Caecum Metabolome, and Markers of Lipid Metabolism in ob/ob Mice.

Mol Nutr Food Res 2019 09 25;63(17):e1900403. Epub 2019 Jun 25.

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, 31024, France.

View Article and Find Full Text PDF
September 2019

SCFAs - the thin microbial metabolic line between good and bad.

Authors:
Matteo Serino

Nat Rev Endocrinol 2019 06;15(6):318-319

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.

View Article and Find Full Text PDF
June 2019

Structure function relationships in three lipids A from the Ralstonia genus rising in obese patients.

Biochimie 2019 Apr 28;159:72-80. Epub 2019 Jan 28.

I2BC, Centre National de la Recherche Scientifique, Université de Paris-Sud, Université de Paris-Saclay, Orsay, France; LPS-BioSciences, I2BC, Bâtiment 409, Université de Paris-Sud, Orsay, France. Electronic address:

View Article and Find Full Text PDF
April 2019

Oral health and microbiota status in professional rugby players: A case-control study.

J Dent 2018 12 5;79:53-60. Epub 2018 Oct 5.

INSERM U1048, F-31432 Toulouse, France, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), F-31432 Toulouse, France; Université Paul Sabatier III (UPS), F-31432 Toulouse, France; CHU Toulouse, Service d'Odontologie Toulouse, F-3100, France. Electronic address:

View Article and Find Full Text PDF
December 2018

Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections.

Authors:
Matteo Serino

J Mol Biol 2018 03 31;430(5):581-590. Epub 2018 Jan 31.

IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France. Electronic address:

View Article and Find Full Text PDF
March 2018

Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity.

Mol Nutr Food Res 2018 02 29;62(3). Epub 2017 Dec 29.

Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IdIBGi), CIBEROBN (CB06/03/010) and Instituto de Salud Carlos III (ISCIII), Girona, Spain.

View Article and Find Full Text PDF
February 2018

Gestational diabetes is associated with changes in placental microbiota and microbiome.

Pediatr Res 2016 12 4;80(6):777-784. Epub 2016 Aug 4.

Department of Endocrinology, Dr. Josep Trueta Hospital and Girona Institute for Biomedical Research and CIBERobn, Girona, Spain.

View Article and Find Full Text PDF
December 2016

Periodontal dysbiosis linked to periodontitis is associated with cardiometabolic adaptation to high-fat diet in mice.

Am J Physiol Gastrointest Liver Physiol 2016 06 31;310(11):G1091-101. Epub 2016 Mar 31.

Institut National de la Santé et de la Recherche Médicale U1048 and Institut des Maladies Métaboliques et Cardiovasculaires, Toulouse, France; Université Paul Sabatier, Toulouse, France; Faculté de Chirurgie-Dentaire de Toulouse, Toulouse, France; and

View Article and Find Full Text PDF
June 2016

Gut Microbiota Interacts With Brain Microstructure and Function.

J Clin Endocrinol Metab 2015 Dec 7;100(12):4505-13. Epub 2015 Oct 7.

Department of Diabetes, Endocrinology and Nutrition (J.-M.F.-R., W.R.), Institut d'Investigació Biomédica de Girona, CIBER de la Fisiopatología de la Obesidad y la Nutrición (CIBERobn, CB06/03/0010) and Instituto de Salud Carlos III, Girona, 17007 Spain; Institut National de la Santé et de la Recherche Médicale (M.S., R.B.), Toulouse, France; Unité Mixte de Recherche 1048 (M.S., R.B.), Institut de Maladies Métaboliques et Cardiovasculaires, Université Paul Sabatier, F-31432 Toulouse Cedex 4, France; Girona Biomedical Research Institute, Department of Radiology-Institut de Diagnostic per la Imatge (G.B., J.P.), Hospital Universitari Dr Josep Trueta, Girona, 17007 Spain; Department of Computer Science, Applied Mathematics, and Statistics (J.D.-E.), University of Girona, Girona, 17071 Spain; Department of Psychiatry (F.F.-A.), University Hospital of Bellvitge-IDIBELL, Barcelona, CIBERobn, Instituto Salud Carlos III, Barcelona, 08908 Spain; and Nutren Group, Department of Experimental Medicine (M.P.-O.), PCiTAL-IRBLleida-Universitat de Lleida, Lleida, 25198 Spain.

View Article and Find Full Text PDF
December 2015

Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.

Curr Cardiol Rep 2014 Nov;16(11):540

Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France,

View Article and Find Full Text PDF
November 2014

Metabolic endotoxemia directly increases the proliferation of adipocyte precursors at the onset of metabolic diseases through a CD14-dependent mechanism.

Mol Metab 2013 4;2(3):281-91. Epub 2013 Jul 4.

Institut National de la Santé et de la Recherche Médicale (INSERM) U1048, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France ; Université Paul Sabatier, Toulouse, France.

View Article and Find Full Text PDF
September 2013

Metagenome and metabolism: the tissue microbiota hypothesis.

Diabetes Obes Metab 2013 Sep;15 Suppl 3:61-70

Institut National de Santé et de Recherche Médicale (INSERM), U1048, Toulouse, France.

View Article and Find Full Text PDF
September 2013

[Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].

Med Sci (Paris) 2013 Aug-Sep;29(8-9):800-6. Epub 2013 Sep 5.

Institut des maladies métaboliques et cardiovasculaires, hôpital Rangueil, Toulouse Cedex, France.

View Article and Find Full Text PDF
November 2013

Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes.

J Mol Med (Berl) 2013 Apr 4;91(4):523-34. Epub 2012 Dec 4.

Department of Diabetes, Endocrinology and Nutrition (UDEN), Institut d'Investigació Biomédica de Girona (IdIBGi), CIBER de la Fisiopatología de la Obesidad y la Nutrición (CIBERobn, CB06/03/0010) and Instituto de Salud Carlos III (ISCIII), Girona, Spain.

View Article and Find Full Text PDF
April 2013

Microbes on-air: gut and tissue microbiota as targets in type 2 diabetes.

J Clin Gastroenterol 2012 Oct;46 Suppl:S27-8

Institut National de la Santé et de Recherche Médicale (INSERM), Toulouse, France.

View Article and Find Full Text PDF
October 2012

Intestinal MicrobiOMICS to define health and disease in human and mice.

Curr Pharm Biotechnol 2012 Apr;13(5):746-58

Université de Toulouse, UPS, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse cedex, France.

View Article and Find Full Text PDF
April 2012

Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.

Acta Diabetol 2011 Dec 2;48(4):257-273. Epub 2011 Oct 2.

Department of Therapeutics, Rangueil Hospital, Toulouse, France.

View Article and Find Full Text PDF
December 2011

CD14 modulates inflammation-driven insulin resistance.

Diabetes 2011 Aug 23;60(8):2179-86. Epub 2011 Jun 23.

Section of Diabetes, Endocrinology and Nutrition, University Hospital of Girona, Biomedical Research Institute Dr Josep Trueta and CIBERobn Fisiopatología de la Obesidad y Nutrición, Girona, Spain.

View Article and Find Full Text PDF
August 2011

Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control.

PLoS One 2011 6;6(6):e20700. Epub 2011 Jun 6.

Institut National de la Santé et de la Recherche Médicale U1048, Institut de recherche sur les Maladies Métaboliques et Cardiovasculaire, I2MC, Toulouse, France.

View Article and Find Full Text PDF
September 2011

A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism.

Curr Opin Pharmacol 2009 Dec 30;9(6):744-52. Epub 2009 Sep 30.

Rangueil Institute of Molecular Medicine, I(2)MR, U858 Inserm, IFR31, BP 84225, Toulouse, France.

View Article and Find Full Text PDF
December 2009

The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?

Front Biosci (Landmark Ed) 2009 Jun 1;14:5107-17. Epub 2009 Jun 1.

Rangueil Institute of Molecular Medicine, I2MR, U858 Inserm, IFR31, Toulouse, France.

View Article and Find Full Text PDF
June 2009